{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T13:29:48Z","timestamp":1778333388164,"version":"3.51.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Risperidone, aripiprazole, and pipamperone are antipsychotic drugs frequently prescribed for the treatment of comorbid behavioral problems in children with autism spectrum disorders. Therapeutic drug monitoring (TDM) could be useful to decrease side effects and to improve patient outcome. Dried blood spot (DBS) sample collection seems to be an attractive technique to develop TDM of these drugs in a pediatric population. The aim of this work was to develop and validate a DBS assay suitable for TDM and home sampling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Risperidone, 9-OH risperidone, aripiprazole, dehydroaripiprazole, and pipamperone were extracted from DBS and analyzed by ultra\u2013high-performance liquid chromatography\u2013tandem mass spectrometry using a C18 reversed-phase column with a mobile phase consisting of ammonium acetate\/formic acid in water or methanol. The suitability of DBS for TDM was assessed by studying the influence of specific parameters: extraction solution, EDTA carryover, hematocrit, punching location, spot volume, and hemolysis. The assay was validated with respect to conventional guidelines for bioanalytical methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The method was linear, specific without any critical matrix effect, and with a mean recovery around 90%. Accuracy and imprecision were within the acceptance criteria in samples with hematocrit values from 30% to 45%. EDTA or hemolysis did not skew the results, and no punching carryover was observed. No significant influence of the spot volume or the punch location was observed. The antipsychotics were all stable in DBS stored 10 days at room temperature and 1 month at 4 or \u221280\u00b0C. The method was successfully applied to quantify the 3 antipsychotics and their metabolites in patient samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>A UHPLC-MS\/MS method has been successfully validated for the simultaneous quantification of risperidone, 9-OH risperidone, aripiprazole, dehydroaripiprazole, and pipamperone in DBS. The assay provided good analytical performances for TDM and clinical research applications.<\/jats:p><\/jats:sec>","DOI":"10.1097\/ftd.0000000000000411","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T18:04:21Z","timestamp":1499882661000},"page":"429-440","source":"Crossref","is-referenced-by-count":27,"title":["Dried Blood Spots Combined With Ultra\u2013High-Performance Liquid Chromatography\u2013Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites"],"prefix":"10.1097","volume":"39","author":[{"given":"Camille","family":"Tron","sequence":"first","affiliation":[{"name":"Hospital Pharmacy,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne M.","family":"Kloosterboer","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy,"},{"name":"Child and Adolescent Psychiatry\/Psychology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart C. H.","family":"van der Nagel","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rixt A.","family":"Wijma","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram","family":"Dierckx","sequence":"additional","affiliation":[{"name":"Child and Adolescent Psychiatry\/Psychology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwen C.","family":"Dieleman","sequence":"additional","affiliation":[{"name":"Child and Adolescent Psychiatry\/Psychology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teun","family":"van Gelder","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy,"},{"name":"Internal Medicine, Erasmus MC, Rotterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit C. P.","family":"Koch","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","first-page":"25","article-title":"Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012","volume":"111","author":"Bachmann","year":"2014","journal-title":"Dtsch Arztebl Int."},{"key":"R2-20230814","first-page":"1","article-title":"Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder","volume":"11","author":"Dinnissen","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000030","article-title":"Psychopharmacological interventions in autism spectrum disorders","volume":"42","author":"Politte","year":"2014","journal-title":"Harv Rev Psychiatry."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/YCO.0000000000000132","article-title":"An update on pharmacotherapy for autism spectrum disorder in children and adolescents","volume":"28","author":"Young","year":"2015","journal-title":"Curr Opin Psychiatry."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiatry."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/cap.2008.007","article-title":"Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents","volume":"19","author":"Calarge","year":"2009","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/JCP.0b013e3182549259","article-title":"Adverse effects of second-generation antipsychotics in children and adolescents","volume":"32","author":"Cohen","year":"2012","journal-title":"J Clin Psychopharmacol."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0269881113515064","article-title":"Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics","volume":"28","author":"Silvestre","year":"2014","journal-title":"J Psychopharmacol."},{"key":"R9-20230814","first-page":"1413","article-title":"Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group","volume":"2","author":"Baumann","year":"2006","journal-title":"Rev Med Suisse."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00007691-200404000-00014","article-title":"Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline","volume":"26","author":"Baumann","year":"2004","journal-title":"Ther Drug Monit."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0924-9338(00)00536-8","article-title":"Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels","volume":"16","author":"Mauri","year":"2001","journal-title":"Eur Psychiatry."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/FTD.0b013e3182708ec5.","article-title":"Therapeutic drug monitoring of common antipsychotics","volume":"34","author":"Patteet","year":"2012","journal-title":"Ther Drug Monit."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00406-004-0556-4","article-title":"Risperidone plasma levels, clinical response and side-effects","volume":"255","author":"Riedel","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000054932","article-title":"Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms","volume":"44","author":"Yoshimura","year":"2001","journal-title":"Neuropsychobiology"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","article-title":"Clinical pharmacokinetics of atypical antipsychotics","volume":"46","author":"Mauri","year":"2007","journal-title":"Clin Pharmacokinet."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/cap.2014.0044","article-title":"Therapeutic drug levels of second generation antipsychotics in youth: a systematic review","volume":"25","author":"Whitney","year":"2015","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40272-013-0024-6","article-title":"Safety and pharmacokinetics of atypical antipsychotics in children and adolescents","volume":"15","author":"Caccia","year":"2013","journal-title":"Paediatr Drugs."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dta.1646","article-title":"Dried blood spots: concepts, present status, and future perspectives in bioanalysis","volume":"6","author":"Sharma","year":"2014","journal-title":"Drug Test Anal."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.4155\/bio.13.175","article-title":"State-of-the-art dried blood spot analysis: an overview of recent advances and future trends","volume":"5","author":"Meesters","year":"2013","journal-title":"Bioanalysis"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","article-title":"Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls","volume":"31","author":"Edelbroek","year":"2009","journal-title":"Ther Drug Monit."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin Pharmacokinet."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.chroma.2012.12.071","article-title":"Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","volume":"1292","author":"Ansermot","year":"2013","journal-title":"J Chromatogr A."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpba.2013.07.041","article-title":"Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","volume":"88","author":"Gradinaru","year":"2014","journal-title":"J Pharm Biomed Anal."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jchromb.2005.06.023","article-title":"Development and validation of an LC-MS\/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma","volume":"822","author":"Kubo","year":"2005","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci."},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cca.2014.12.008","article-title":"Advances in detection of antipsychotics in biological matrices","volume":"441","author":"Patteet","year":"2015","journal-title":"Clin Chim Acta."},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2013.11.024","article-title":"High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry","volume":"429","author":"Patteet","year":"2014","journal-title":"Clin Chim Acta."},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jms.1783","article-title":"Identification and quantification of 30 antipsychotics in blood using LC-MS\/MS","volume":"45","author":"Saar","year":"2010","journal-title":"J Mass Spectrom."},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jpba.2005.05.031","article-title":"Stability indicating LC method for the determination of pipamperone","volume":"39","author":"Trabelsi","year":"2005","journal-title":"J Pharm Biomed Anal."},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/dta.1698","article-title":"The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra-high performance liquid chromatography - tandem mass spectrometry","volume":"7","author":"Patteet","year":"2015","journal-title":"Drug Test Anal."},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1208\/s12248-014-9695-3","article-title":"Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group","volume":"17","author":"Evans","year":"2014","journal-title":"AAPS J."},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bmc.1367","article-title":"Dried blood spot sampling in combination with LC-MS\/MS for quantitative analysis of small molecules","volume":"24","author":"Li","year":"2010","journal-title":"Biomed Chromatogr."},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4155\/bio.13.173","article-title":"Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium","volume":"5","author":"Timmerman","year":"2013","journal-title":"Bioanalysis"},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4155\/bio.11.132","article-title":"EBF recommendation on the validation of bioanalytical methods for dried blood spots","volume":"3","author":"Timmerman","year":"2011","journal-title":"Bioanalysis"},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4155\/bio.14.298","article-title":"What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?","volume":"7","author":"Koster","year":"2015","journal-title":"Bioanalysis"},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2257.1997.00204.x","article-title":"Haematological reference ranges for schoolchildren","volume":"19","author":"Taylor","year":"1997","journal-title":"Clin Lab Haematol."},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/bmc.3610","article-title":"Identification and quantification of the antipsychotics risperidone, aripiprazole, pipamperone and their major metabolites in plasma using ultra-high performance liquid chromatography-mass spectrometry","volume":"30","author":"Wijma","year":"2016","journal-title":"Biomed Chromatogr."},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1570-0232(02)00914-5","article-title":"Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry","volume":"785","author":"Polson","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem."},{"key":"R42-20230814","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/ac303014b","article-title":"Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer","volume":"85","author":"Capiau","year":"2013","journal-title":"Anal Chem."},{"key":"R43-20230814","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0883073807307102","article-title":"Autism spectrum disorders: concurrent clinical disorders","volume":"23","author":"Ming","year":"2008","journal-title":"J Child Neurol."},{"key":"R44-20230814","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4155\/bio.11.219","article-title":"Perforated dried blood spots: a novel format for accurate microsampling","volume":"3","author":"Li","year":"2011","journal-title":"Bioanalysis"},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4155\/bio.11.337","article-title":"Managing the effect of hematocrit on DBS analysis in a regulated environment","volume":"4","author":"Fan","year":"2012","journal-title":"Bioanalysis"},{"key":"R46-20230814","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal Chem."},{"key":"R47-20230814","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/ac503931g","article-title":"New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis","volume":"87","author":"Leuthold","year":"2015","journal-title":"Anal Chem."},{"key":"R48-20230814","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jms.3015","article-title":"Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection","volume":"47","author":"Li","year":"2012","journal-title":"J Mass Spectrom."},{"key":"R49-20230814","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4155\/bio.12.175","article-title":"Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis","volume":"4","author":"Meesters","year":"2012","journal-title":"Bioanalysis"},{"key":"R50-20230814","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/rcm.5182","article-title":"Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact","volume":"25","author":"Youhnovski","year":"2011","journal-title":"Rapid Commun Mass Spectrom."},{"key":"R51-20230814","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jac\/dks011","article-title":"Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz","volume":"67","author":"Kromdijk","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"R52-20230814","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.4155\/bio.15.100","article-title":"Are capillary DBS applicable for therapeutic drug monitoring of common antipsychotics? A proof of concept","volume":"7","author":"Patteet","year":"2015","journal-title":"Bioanalysis"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201708000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T03:26:32Z","timestamp":1750562792000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201708000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000411","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}